The software giant joins rivals IBM and Google in putting supercomputing to work on cancer research and treatment.
The organizations are building a research laboratory for brain-inspired machine comprehension to develop systems that mimic certain human abilities.
A guide to the annual event taking place in Washington, DC next week, as well as virtual and live gatherings around the country. Topical and timely themes include precision medicine, telehealth, interoperability and population health.
In an early-adopter program at the National Institutes of Health, the cloud-based genomics platform will be used to gauge how best to deliver precision medicine data to clinicians at the point of care.
The initiative will offer advanced technologies and genomic profiling to nearly 150 hospitals, focusing first on cancer treatment, hospital executives said.
No approved commercial tests are available, and processing the emergency-use tests FDA temporarily authorized takes too long and raises concerns about accuracy. Researchers are working to streamline that process.
The second Pop Health Forum 2016 took place in Chicago with expert speakers, panelists and healthcare professionals discussing pressing issues, from analytics to chronic care management to telehealth. Here’s a roundup of what happened.
The deal marks the first testing collaboration for Intermountain Precision Genomics outside of the U.S.
The technology leverages the company’s 175 million patient-record years and a patient’s medical history to predict the patient’s future health.
The $8.2 million deal with Moderna aims to accelerate the development of vaccine technology and is expected to be faster than other approaches in developing vaccines.